£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

Myeloproliferative Disorder Drugs Outlook in India 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 17 days · 17 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 12 August 2026 16 August 2026 20 August 2026 24 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 74 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 17 days • 1 price levels

Days at Price
17 days 0 4 9 13 17 £515 Days at Price

Price Analysis

Most common price: £515 (17 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 17 days

Description

This comprehensive study provides a detailed analysis of the latent demand for myeloproliferative disorder drugs in India from 2023 to 2028. It offers essential market intelligence by estimating potential industry earnings (P.I.E.) in millions of U.S. dollars across more than 4,900 cities. By reporting the percent share of each city relative to its state, union territory, and the country as a whole, this report provides the comparative benchmarks necessary for effective decision-making. The statistical approach contained in this work is designed to support the development of efficient distribution and sales force strategies throughout the Indian market.

Key Features

Provides latent demand outlooks for myeloproliferative disorder drugs in India from 2023 to 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars.

Covers market data for over 4,900 cities, states, and union territories across India.

Offers comparative benchmarks by reporting the percent share of each city against its state and the nation.

Supports the development of strategic distribution and sales force planning through statistical analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

US Myeloproliferative Disorder Drug Outlook 2023-2028
99% match

US Myeloproliferative Disorder Drug Outlook 2023-2028

£520.00 02 Sep 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China
99% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China

£495.00 25 Aug 2026
2025-2030 World Outlook Myeloproliferative Disorder Drugs
98% match

2025-2030 World Outlook Myeloproliferative Disorder Drugs

Price unavailable
Myeloproliferative Disorder Drug Outlook 2023-2028 Report
98% match

Myeloproliferative Disorder Drug Outlook 2023-2028 Report

£490.00 29 Aug 2026
Erythropoietin Drugs US Outlook 2023-2028 Study Report
97% match

Erythropoietin Drugs US Outlook 2023-2028 Study Report

£520.00 03 Sep 2026
Erythropoietin Drugs India Outlook 2023-2028 Study
97% match

Erythropoietin Drugs India Outlook 2023-2028 Study

£515.00 28 Oct 2026
Anti-Malarial Drugs in India Outlook 2023-2028 Report
97% match

Anti-Malarial Drugs in India Outlook 2023-2028 Report

£515.00 06 Nov 2026
US Medical Foods Outlook 2023-2028 Market Study Report
97% match

US Medical Foods Outlook 2023-2028 Market Study Report

£520.00 07 Nov 2026
The 2016-2021 Outlook for Erythropoietins in the United States
97% match

The 2016-2021 Outlook for Erythropoietins in the United States

£595.00 28 Aug 2026
Mobile Content Delivery Networks India Outlook 2023-2028
97% match

Mobile Content Delivery Networks India Outlook 2023-2028

£515.00 07 Nov 2026
India Personal Mobility Devices Outlook 2023-2028 Study
96% match

India Personal Mobility Devices Outlook 2023-2028 Study

£515.00 05 Nov 2026
Advanced Therapy Medicinal Products Outlook India 2023-2028
96% match

Advanced Therapy Medicinal Products Outlook India 2023-2028

£515.00 06 Nov 2026
2023-2028 US Advanced Therapy Medicinal Products Outlook
96% match

2023-2028 US Advanced Therapy Medicinal Products Outlook

£520.00 05 Nov 2026
Mobile Device Management (MDM) India Outlook 2023-2028
96% match

Mobile Device Management (MDM) India Outlook 2023-2028

£515.00 26 Aug 2026
Mobile Medical Apps in India Outlook 2023-2028 Report
96% match

Mobile Medical Apps in India Outlook 2023-2028 Report

£515.00 07 Nov 2026
The 2016-2021 Outlook for Hematology Instruments and Reagents in India
96% match

The 2016-2021 Outlook for Hematology Instruments and Reagents in India

£595.00 26 Aug 2026
US Personal Mobility Devices Outlook 2023-2028 Study
96% match

US Personal Mobility Devices Outlook 2023-2028 Study

£520.00 03 Nov 2026
Anti-Viral Nucleotide Polymerase Inhibitor Drugs India Study
96% match

Anti-Viral Nucleotide Polymerase Inhibitor Drugs India Study

£515.00 06 Nov 2026
Mobile Health Platforms in India 2023-2028 Outlook Study
96% match

Mobile Health Platforms in India 2023-2028 Outlook Study

£515.00 09 Nov 2026
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
96% match

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

£595.00 05 Nov 2026
Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook
96% match

Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
Mobile Technologies in India 2023-2028 Outlook Study
96% match

Mobile Technologies in India 2023-2028 Outlook Study

£515.00 02 Nov 2026
Mobile Health in India 2023-2028 Outlook - Market Study
96% match

Mobile Health in India 2023-2028 Outlook - Market Study

£515.00 05 Nov 2026
Mobile Healthcare in India 2023-2028 Outlook Study Report
96% match

Mobile Healthcare in India 2023-2028 Outlook Study Report

£515.00 04 Nov 2026